ghrelin antagonists (Elixir/Novartis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameghrelin antagonists (Elixir/Novartis)
Drug Alias Nameghrelin antagonists (Elixir)EX-1311EX-1350EX-51EX-1832 +[6] 
ClassificationSmall molecules
Mechanisms of ActionAppetite suppressantGhrelin/growth hormone secretagogue receptor antagonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElixir Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis AgElixir Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A